In invasive pancreatic cancer patient samples, MCP1 was found to be expressed in 60% of the cases and the majority of samples assessed were from smokers; further, MCP1 colocalized with OPN in invasive patient tissue samples [119]. This evidence concerns the gene CCL2 and familial pancreatic carcinoma.